Objective: To assess the vitamin D status of healthy young people living in Northern Ireland and the effect of vitamin D supplementation on vitamin D status and bone turnover. Design: Double-blinded randomised controlled intervention study. Setting: University of Ulster, Coleraine, Northern Ireland. Subjects: In total, 30 apparently healthy students (15 male and 15 female subjects), aged 18-27 years, were recruited from the university, with 27 completing the intervention. Interventions: Subjects were randomly assigned, to receive either 15 mg (600 IU) vitamin D 3 and 1500 mg calcium/day (vitamin D group), or 1500 mg calcium/day (control group) for 8 weeks between January and March. Vitamin D status, bone turnover markers, serum calcium and parathyroid hormone concentrations were measured at baseline and post intervention. 
Introduction
Vitamin D plays a central role in bone mineralisation by regulating calcium and phosphate metabolism (Suda et al., 2003) , such that vitamin D deficiency leads to hyperparathyroidism, increased bone turnover, rickets, osteoporosis and mild osteomalacia, and an increased risk of hip and other fractures (Dawson-Hughes et al., 1991; Hutchison and Bell, 1992; Martinez et al., 1994; Aguado et al., 2000; Cheng et al., 2003; Isaia et al., 2003) . More recently, observational studies have also reported that vitamin D intake is inversely associated with the incidence of a number of conditions, including cancer and autoimmune disorders such as rheumatoid arthritis, multiple sclerosis and type I diabetes mellitus (Bostick et al., 1993; Hypponen et al., 2001; Merlino et al., 2004; Munger et al., 2004) .
In humans, vitamin D is obtained predominantly from cutaneous synthesis through a process initiated via sunlight exposure, by UV irradiation on the skin (Webb et al., 1988) . In countries around the equator, UV light and, therefore, the production of vitamin D, is constant throughout the year (Glerup et al., 2000) . However, seasonal variation in UV intensity, as occurs both far North and South of the equator, results in marked variation in vitamin D status throughout the year, with highest concentrations found in late summer and markedly lower concentrations observed in late winter (McLaughlin et al., 1974; McKenna, 1992) . This seasonal pattern is apparent in all European countries, but is particularly evident in northern European countries, including the UK and Ireland, which are located at 50-601N (Ovesen et al., 2003; Zittermann, 2003) . There is currently no dietary reference value (DRV) for vitamin D for adults aged 18-50 years, in the UK and Ireland, as it is assumed that there is sufficient cutaneous synthesis of vitamin D from sunlight exposure (SACN report, 2003) . Moreover, it has generally been assumed that enough of the vitamin is synthesised in the body to meet daily requirements. However, vitamin D intakes are generally low (Lehtonen-Veromaa et al., 1999; Brot et al., 2001; Ginty et al., 2004; Moore et al., 2004) compared to the DRVs of 7-8.5 mg/day for young children and 10 mg/day for those over 65 years and pregnant and lactating women (SACN report, 2003) , groups who are known to be at-risk of deficiency. A recent study has shown that Irish adults have very low vitamin D intakes, averaging around only 3.2 mg/day (128 IU/day) from food alone (Hill et al., 2004) . This may be because there are only a limited number of food sources containing small amounts of vitamin D and include: oily fish, liver, egg yolks and a few fortified margarines and breakfast cereals. Therefore, during the winter period, when vitamin D synthesis is negligible, most people in northern Europe rely on the stores built up in the body during the previous summer. There is ongoing debate on the plasma 25(OH)D concentrations which are regarded as sufficient. Studies have used various biomarkers to define vitamin D sufficiency, such as changes in PTH concentrations and effects on bone metabolism (Lips et al., 1988; Bates et al., 2003) . Plasma 25(OH)D concentrations of o25 (Parfitt, 1998; SACN report, 2003) , 30 (Lips et al., 1988) and 50 (Lips, 2004) nmol/l have been suggested as cutoff levels for insufficiency, with the recommendation of o50 nmol/l being widely used in recent studies investigating vitamin D status.
It is perhaps not surprising that epidemiological studies have reported low vitamin D status in countries which have low UV exposure for much of the year (McKenna, 1992; Lips, 2001; Ovesen et al., 2003) . The majority of these studies have been carried out on postmenopausal women and elderly people owing to the greater risk of osteoporosis in these individuals. More recent studies have also reported low vitamin D status in younger adults, adolescents and children living at higher latitudes (Ala-Houhala et al., 1984; LambergAllardt et al., 1986; McKenna, 1992; Lehtonen-Veromaa et al., 1999; Fuleihan et al., 2001; Guillemant et al., 2001; Tangpricha et al., 2002; Ginty et al., 2004; Gordon et al., 2004) . Given the role of vitamin D in bone mineralisation, vitamin D insufficiency is highly likely to have deleterious effects on bone mineral density (BMD) in this group, and thereby decreasing their ability to achieve their potential peak bone mass (Bonjour et al., 1994; Lehtonen-Veromaa et al., 2002a, b) . In contrast, a high dietary vitamin D intake in adolescence has been reported to positively influence BMD in young adults (Neville et al., 2002) . Optimisation of BMD at a young age through enhanced vitamin D status may reduce the risk of osteoporosis in such individuals in later life.
The current study aims to assess the vitamin D status of healthy young people living in Northern Ireland at a latitude of 551N, in wintertime when vitamin D synthesis is negligible. It also aims to assess the effect of vitamin D supplementation on plasma 25-hydroxyvitamin D (25(OH)D) levels (the status marker for the vitamin) and on bone turnover markers, which are reported to be the most sensitive methods for monitoring acute changes in bone metabolism.
Subjects and methods

Design
This double-blinded randomised controlled intervention study was approved by the Research Ethics Committee of the University of Ulster and all participants gave written informed consent before the commencement of the study. By using data collected previously (Vieth et al., 2001 ) and allowing for a 10% drop-out rate, it was calculated that 30 individuals should be recruited to see a significant effect of supplementation (at Po0.05) on vitamin D status.
Subjects
In total, 30 apparently healthy individuals, 15 male and 15 female, aged 18-27 years, were recruited from among the student population within the University of Ulster. Subjects were randomly assigned to two groups, to receive either Calcichew s D 3 supplements, containing 15 mg (600 IU) vitamin D 3 and 1500 mg calcium/day (vitamin D group), or Calcichew s , containing 1500 mg calcium/day (control group) (Shire Pharmaceuticals, UK) for 8 weeks between January and March. A commercially available source of vitamin D alone was not obtainable at the time of the study, so supplements with added calcium at high levels were needed in order to achieve the desirable dose of vitamin D. Height and weight were measured at baseline and body mass index (BMI) was calculated. All subjects had a BMI of less than 30 kg/m 2 , were nonsmokers, not on any special diets, not taking any dietary supplements, did not normally expose themselves to artificial sources of UV light, had not taken a sun holiday before the study and were not planning a holiday during the intervention period.
Dietary assessment
A 4-day food diary was completed by all subjects at baseline and daily calcium and vitamin D intakes were analysed using the dietary analysis program WISP (WISP for WINDOWS, version 3.0, Tinuviel Software, Warrington, UK).
Blood collection
Venous blood was collected following an overnight (12-h) fast, by a trained phlebotomist between 0830 and 1000 hours at baseline and post intervention. Blood was collected into a 9 ml serum separator tube and a 4 ml EDTA tube for analysis of bone turnover markers, vitamin D status and parathyroid hormone (PTH) concentration. A 4 ml serum tube was collected last, with the tourniquet off for measurement of calcium. All tubes were allowed to stand at room temperature before centrifugation at 2000 r.p.m. for 20 min. Samples were aliquoted and frozen at -201C for a maximum of two months.
Calcium, PTH concentration and vitamin D status
Total serum calcium was assessed immediately following sample collection, at baseline and post intervention, using the Roche Diagnostics colorimetric assay on a Hitachi 912 analyser (Roche Diagnostics, UK). Intact plasma PTH concentrations were measured by an electrochemiluminescence immunoassay (ECLIA) on the Elecsys Module (Roche Diagnostics, UK).
Vitamin D status was assessed by quantitatively measuring plasma 25(OH)D using OCTEIA 25(OH)D enzyme immunoassay (ELISA) kit (Immunodiagnostic Systems Limited (IDS), UK), following the manufacturer's instructions. The IDS OCTEIA 25(OH)D kit is an ELISA in a microtitre strip format utilising 25(OH)D sheep polyclonal antibody coated on the strip to capture 25(OH)D in the sample. The enzyme activity of the captured 25(OH)D was detected with a tetramethylbenzidine (TMB) substrate at a wavelength of 450 nm (reference 650 nm). All samples were measured in duplicate and mean absorbance for each sample calculated. Percentage binding (B/Bo%) of each calibrator, control and sample was calculated as: mean absorbance divided by mean absorbance for '0' calibrator Â 100. A point-to-point smoothed spline calibration curve was plotted using GraphPad Prism 3 (GraphPad Software Inc., USA) on Microsoft Windows XP and the 25(OH)D concentration of each sample was calculated. The sensitivity of the OCTEIA 25(OH)D ELISA kit is 5 nmol/l. The interassay coefficient of variation (CV) was 3.88% and the intra-assay CV was 4.41%.
Bone turnover markers Bone formation. Bone-specific alkaline phosphatase (BAP) was quantitatively measured by Metra BAP ELISA (Quidel, Oxford Biosystems, UK). Metra BAP is an immunoassay in a microtitre strip format utilising a monoclonal anti-BAP antibody coated on the strip to capture BAP in the sample. The enzyme activity of the BAP was detected with a pnitrophenyl phosphate substrate at a wavelength of 405 nm. The sensitivity of this kit was 0.7 U/l, the interassay CV was 2.57% and the intra-assay CV was 2.71%.
Bone resorption. An ELISA for the quantification of degradation products of C-terminal telopeptides of type I collagen in human serum (Serum CrossLaps, Nordic Bioscience Diagnostics, Denmark) was used as a marker of bone resorption. The serum crosslaps immunoassay is a microtitre strip coated with streptavidin and uses a biotinylated antibody, a peroxidase-conjugated murine monoclonal antibody specific for serum crosslaps and a TMB substrate to measure enzyme activity at a wavelength of 450 nm (reference 650 nm). The sensitivity of the assay was 0.9 ng/ml, the interassay CV was 9.19% and the intra-assay CV was 2.93%
Statistical analysis
All analyses were performed using SPSS (SPSS Inc., version 11.0, Chicago) on Microsoft Windows XP. Data were normally distributed and are presented as means (standard deviations). Baseline characteristics and mean daily nutrient intakes reported by the control and vitamin D-treated groups, were compared by means of a two-tailed independent samples t-test. A one-way between groups analysis of covariance (ANCOVA) was conducted to compare the effect of treatment, with a P-value o0.05 considered significant in all analyses.
Results
Of the 30 individuals originally recruited to the study, one subject did not complete because of illness and two subjects failed to give a blood sample post intervention. Thus, the results of 27 subjects who provided complete data were included in the final analyses.
There were no statistically significant differences at baseline in anthropometric characteristics or nutritional intakes between the control group and the vitamin D-treated group (Table 1) . The mean daily intakes of calcium were above the recommended nutrient intake (RNI) of 700 mg/day (Department of Health, 1991) and the main dietary sources of vitamin D, which contributed more than 10% of the dietary vitamin D were eggs, cheese, milk, margarine and cereals (data not shown). Laboratory results for baseline and post supplementation measurements for both groups are presented in Table 2 . At baseline, one subject was vitamin D deficient according to the cutoff level of o25 nmol/l (Parfitt et al., 1982 ; Department of Health, 1998), whereas no subjects were deficient post supplementation. A level of 30 nmol/l has also been suggested as the cutoff for vitamin D deficiency (Lips et al., 1988 ). According to this higher level, 14.8% (n ¼ 4, all in control group) of our subjects were deficient at baseline and post supplementation. There was no significant change in serum calcium levels post supplementation. The functional marker of vitamin D status, PTH was within the normal range (15-65 pg/ml) in both groups at baseline and post supplementation and were not significantly altered by vitamin D supplementation. Regression analysis was conducted to correct for baseline vitamin D concentrations to assess if changes in biochemical measurements, including PTH, between the two groups were different (data not shown). There were no significant differences between the two groups after adjusting for baseline vitamin D concentrations.
Discussion
Although a considerable number of studies have examined vitamin D status and the effect of supplementation on status in older populations (Lips et al., 1988; Liu et al., 1997; Harris et al., 2000) , fewer studies have examined young people. Such studies are of particular importance among those living at higher latitudes where maintenance of sufficient vitamin D levels may be a problem given low UV exposure in wintertime (Tangpricha et al., 2002) .
Research to date has indicated that the usual dietary vitamin D intake in Europe is not sufficient to maintain adequate vitamin D status during wintertime when synthesis is minimal (Holick, 1994; Glerup et al., 2000; Ovesen et al., 2003; Hill et al., 2004) . The results of the current study support this hypothesis. The estimated overall mean dietary intake was 2.05 mg/day (82 IU/day), an intake which is even lower than that observed in an earlier study which estimated the mean dietary intake of Irish adults to be 3.2 mg/day (128 IU/day) (Hill et al., 2004) . This lower intake may be explained by the age group in the current study and suggest that young adults may have particularly low vitamin D intakes. It is perhaps not surprising, therefore, that we also observed a mean baseline plasma 25(OH)D concentration of 52.1 (17.6) nmol/l, a concentration which indicates a vitamin D status bordering on insufficiency (25(OH)D o50 nmol/l) (Lips, 2004) . Our results are comparable with an earlier study conducted among young men living in Boston, (at a latitude of 421N) which reported 25(OH)D levels of 54.4 (16.8) nmol/l during wintertime (Harris and Dawson-Hughes, 2002) . It is worth noting, however, that different vitamin D assays give different results (Chen et al., 1990) and the IDS ELISA has 75% specificity for vitamin D 3 , and thus may underestimate vitamin D status. Other wintertime studies of vitamin D status have also found insufficient serum 25(OH)D concentrations among young people living in France and Finland (Guillemant et al., 2001; Lehtonen-Veromaa et al., 2002a, b) .
In the current study, 8 weeks supplementation with 15 mg (600 IU) vitamin D 3 /day significantly increased vitamin D status. Post supplementation samples were taken at the end of March, when vitamin D status is naturally expected to be at its lowest. Other vitamin D supplementation studies have shown similar increases in serum 25(OH)D concentrations Vitamin D status, supplementation and bone turnover in young adults MS Barnes et al and corrections of wintertime insufficiency. These studies have, however, only been conducted at geographical latitudes with a higher exposure to UVB irradiation. Harris and Dawson-Hughes (2002) gave 20 mg (800 IU) vitamin D 3 /day for 8 weeks during wintertime to young men living in Boston (421N), and reported that serum 25(OH)D concentrations increased by 22.5 nmol/l from a baseline value of 59.9 nmol/ l. Although vitamin D status was significantly improved in the current study, the plasma concentration of 25(OH)D remained well below the level reported by some researchers to be optimal for health (100 nmol/l) (Vieth, 2004) . Although plasma 25(OH)D levels were raised by supplementation, it cannot be certain that a correction of insufficiency occurred. Whether longer-term supplementation would further increase vitamin D status in this group requires further investigation. To our knowledge, there are no studies examining the effect of vitamin D supplementation on bone turnover markers in young adults. A seasonal variation of biochemical markers of bone turnover has been shown, with a higher turnover reported in wintertime compared to summertime (Chapuy et al., 1996; Woitge et al., 1998) . Mezquita-Raya et al. (2001) observed no significant differences in biochemical markers of bone turnover in postmenopausal women with high and low vitamin D status, although they did observe that individuals with vitamin D insufficiency (25(OH)D o40 nmol/l) had a significantly lower BMD. Evidence has shown that there is a direct relationship between vitamin D status and BMD (Aguado et al., 2000) . In the current study, there was no effect of vitamin D supplementation on the bone turnover markers. Although bone turnover markers are good indicators of bone remodelling, their variability is a major problem in clinical application (Siebel et al., 2002) . Some bone turnover markers also show a marked variation over time, which may cause problems when they are measured in short-term studies. This variation, together with the fact that vitamin D may play a more active role in bone mineralisation rather than bone remodelling (Suda et al., 2003) , may have contributed to the non-significant effect of vitamin D supplementation on the markers measured. Furthermore, studies have shown that a serum/plasma 25(OH)D level between 78 and 95 nmol/l is the threshold for effects on bone metabolism (Krall et al., 1989; Chapuy et al., 1997) , levels higher than observed in this study. There was an approximate 10% reduction in CTx in both groups post supplementation; this decrease was not significant. Whether the improvement in vitamin D status, observed in the current study following supplementation is sufficient to promote bone health is unclear and requires investigation in longer-term studies.
There has been considerable debate surrounding the use of PTH as a functional indicator of vitamin D status (Department of Health, 1998). While Pepe et al. (2005) suggested that 25(OH)D concentrations were the main factor determining the circulating levels of PTH, it has also been reported that PTH concentrations only rise when 25(OH)D concentrations are deficient and fall below 40 nmol/l (Mezquita-Raya et al., 2001; Jesudason et al., 2002) . In the current study, we did not observe a direct association between 25(OH)D and PTH levels, and observed that even when 25(OH)D concentrations were very low (o30 nmol/l), PTH remained within normal reference ranges. A study conducted in postmenopausal women corroborates these findings, reporting no correlation between 25(OH)D and PTH at physiological concentrations (Villareal et al., 1991) . Vitamin D only plays a role in the synthesis of PTH, whereas the secretion of the hormone is regulated primarily by calcium (Pepe et al., 2005; Zittermann et al., 1998) . We speculate that no change in PTH concentrations was observed in this study as subjects had adequate dietary intakes of calcium, before supplementation with another 1500 mg calcium/day and were not severely deficient in vitamin D.
In conclusion, the results from the current study provide preliminary data to suggest that young adults in Northern Ireland do not consume an adequate daily dietary intake of vitamin D to maintain plasma vitamin D concentrations in the wintertime. As a consequence, vitamin D insufficiency is likely to be apparent in young adults in Northern Ireland. Clearly there is a need to confirm these results at a population level. A daily supplement of 15 mg (600 IU) vitamin D for 8 weeks significantly increased vitamin D status in these individuals, such that all individuals had sufficient vitamin D status. Achievement of an optimum vitamin D status among young adults may have positive health implications for maintaining bone health, and potentially reducing the incidence of other vitamin Dassociated diseases such as multiple sclerosis and type I diabetes. Undoubtedly, further research is required to define public health policy and guidelines with respect to vitamin D intakes among young adults residing at higher latitudes.
